Signs and Symptoms, Digestive  >>  Goofice (elobixibat)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Goofice (elobixibat) / Ipsen
NCT01833065 / 2012-005588-28: Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation

Terminated
3
314
US, Canada, Europe, RoW
Elobixibat 10 mg/day, A3309, Elobixibat 5 mg/day, Placebo
Ferring Pharmaceuticals
Chronic Idiopathic Constipation
03/14
04/14
NCT01827592 / 2012-005587-94: 26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Terminated
3
376
US, Canada, Europe, RoW
Elobixibat 10 mg, A3309, Elobixibat 5 mg, Placebo
Ferring Pharmaceuticals
Chronic Idiopathic Constipation
03/14
05/14
NCT01895543 / 2012-005601-46: Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation

Completed
3
411
US, Canada, Europe, RoW
Elobixibat 10 mg
Ferring Pharmaceuticals
Chronic Idiopathic Constipation
05/15
05/15

Download Options